U.S. FDA advisers back COVID vaccines for children as young as 6 months

Advisers to the U.S Food and Drug Administration on Wednesday unanimously recommended the agency authorize COVID-19 vaccines from Moderna and Pfizer/BioNTech for millions of the youngest American children. The committee's recommendation is an important step toward immunizing children under the age of 5 and as young as 6 months old who have not yet been eligible for the shots.